CTEV vs EXLS

For growth investors, ExlService Holdings, Inc.

(EXLS) is the stronger pick with 13. 6% revenue growth year-over-year, versus 3. 7% for Claritev Corporation (CTEV). ExlService Holdings, Inc. (EXLS) offers the better valuation at 16. 8x trailing P/E (11. 6x forward), making it the more compelling value choice. Analysts rate Claritev Corporation (CTEV) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, ExlService Holdings, Inc.

(EXLS) delivered a total return of +22. 6%, compared to +0. 8% for Claritev Corporation (CTEV). Over 10 years, the gap is even starker: EXLS returned +149. 3% versus CTEV's +0. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), ExlService Holdings, Inc.

(EXLS) is the lower-risk stock at 0. 42β versus Claritev Corporation's 2. 26β — meaning CTEV is approximately 432% more volatile than EXLS relative to the S&P 500.

By revenue growth (latest reported year), ExlService Holdings, Inc.

(EXLS) is pulling ahead at 13. 6% versus 3. 7% for Claritev Corporation (CTEV). On earnings-per-share growth, the picture is similar: Claritev Corporation grew EPS 83. 0% year-over-year, compared to 27. 3% for ExlService Holdings, Inc.. Over a 3-year CAGR, EXLS leads at 13. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

ExlService Holdings, Inc.

(EXLS) is the more profitable company, earning 12. 0% net margin versus -29. 4% for Claritev Corporation — meaning it keeps 12. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: EXLS leads at 15. 0% versus 4. 7% for CTEV. At the gross margin level — before operating expenses — EXLS leads at 38. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

Analyst consensus price targets imply the most upside for EXLS: 55.

2% to $40. 25.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, ExlService Holdings, Inc.

(EXLS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 42), +149. 3% 10Y return). Claritev Corporation (CTEV) carries a higher beta of 2. 26 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (EXLS: +149. 3%, CTEV: +0. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (CTEV (Healthcare) and EXLS (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: CTEV is a small-cap quality compounder stock; EXLS is a small-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.